BioSpace News Archive

Processa Pharmaceuticals, Inc. (OTC: PCSA) is pleased to announce it has raised a total of $6.88 million from private placements.

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it will participate at the following upcoming investor conferences in June 2018.

Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) has approved the 2-mg dose of OLUMIANT® (baricitinib), a once-daily oral medication for the treatment of adults with moderately-to-severely active rheumatoid arthritis (RA).

Integral Molecular celebrates a milestone of mapping 1,000 epitopes for customers, collaborators, and the NIH.

CHADIS, from Total Child Health was named app of the month by Allscripts for June 2018.

Market research firm Technavio has announced the release of their latest report on the global epilepsy drugs market. This new report will provide expert market insights for the forecast period 2018-2022.

53 adults, ranging from 21 to 74 years of age, put together a spontaneous but intentional fundraising campaign to support children who have been sex trafficked in the Central Ohio region.

EchoNous is applying the emerging field of artificial intelligence (AI) with the extreme miniaturization of ultrasound to solve common everyday problems in health care.

Sarah Cannon announced the appointment of three new research faculty to its drug development programs in Nashville, Tenn. and Denver, Colo.

Canopy Growth Corporation is pleased to announce that it has been selected to apply for five cannabis retail permits by the Saskatchewan Liquor and Gaming Authority (SLGA).